Protection of Epithelial Barrier Function by the Crohn's Disease Associated Gene Protein Tyrosine Phosphatase N2

Gastroenterology

Volumn 137, Issue 6, 2009, Pages

  Scharl, Michael ^a,b   Paul, Gisela ^a   Weber, Achim ^b   Jung, Barbara C ^a   Docherty, Michael J ^a   Hausmann, Martin ^b   Rogler, Gerhard ^b   Barrett, Kim E ^a   McCole, Declan F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 2; GAMMA INTERFERON; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT3 PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 70649104669     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.07.078     Document Type: Article

References (40)

1. Tonks N.K., and Neel B.G. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol 13 (2001) 182-195
2. Franke A., Balschun T., Karlsen T.H., et al. Replication of signals from different studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 40 (2008) 713-715
3. Parkes M., Barrett J.C., Prescott N.J., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39 (2007) 830-832
4. Fisher S.A., Tremelling M., Anderson C.A., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 40 (2008) 710-712
5. The Welcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 447 (2007) 661-678
6. Weersma R.K., Stokkers P.C., Cleynen I., et al. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol 104 (2009) 630-638
7. ten Hoeve J., Ibarra-Sanchez M.J., Fu Y., et al. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol 22 (2002) 5662-5668
8. Lam M.H., Michell B.J., Fodero-Tavoletti M.T., et al. Cellular stress regulates the nucleocytoplasmic distribution of the protein-tyrosine phosphatase TCPTP. J Biol Chem 276 (2001) 37700-37707
9. Tiganis T., Bennett A.M., Ravichandran K.S., et al. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol 18 (1998) 1622-1634
10. Mattila E., Pellinen T., Nevo J., et al. Negative regulation of EGFR signalling through integrin-α1β1-mediated activation of protein tyrosine phosphatase TCPTP. Nat Cell Biol 7 (2005) 78-85
11. Yamamoto T., Sekine Y., Kashima K., et al. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem Biophys Res Commun 297 (2002) 811-817
12. Ibarra-Sanchez M.J., Simoncic P.D., Nestel F.R., et al. The T-cell protein tyrosine phosphatase. Semin Immunol 12 (2000) 379-386
13. Galic S., Klingler-Hoffmann M., Fodero-Tavoletti M.T., et al. Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol 23 (2003) 2096-2108
14. Zhu W., Mustelin T., and David M. Arginine methylation of STAT1 regulates its dephosphorylation by T-cell protein tyrosine phosphatase. J Biol Chem 277 (2002) 35787-35790
15. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
16. Fuss I.J., Neurath M., Boirivant M., et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157 (1996) 1261-1270
17. Stark G.R., Kerr I.M., Williams B.R., et al. How cells respond to interferons. Annu Rev Biochem 67 (1998) 227-264
18. Mudter J., Weigmann B., Bartsch B., et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol 100 (2005) 64-72
19. Schreiber S., Rosenstiel P., Hampe J., et al. Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 51 (2002) 379-385
20. Zeissig S., Burgel N., Gunzel D., et al. Changes in expression and distribution of claudin 2, 5, and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56 (2007) 61-72
21. Prasad S., Mingrino R., Kaukinen K., et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 85 (2005) 1139-1162
22. Amasheh S., Meiri N., Gitter A.H., et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115 (2002) 4969-4976
23. Van Itallie C.M., Holmes J., Bridges A., et al. The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci 121 (2008) 298-305
24. Kinugasa T., Sakaguchi T., Gu X., et al. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118 (2000) 1001-1011
25. Uribe J.M., McCole D.F., and Barrett K.E. Interferon-γ activates EGF receptor and increases TGF-α in T84 cells: implications for chloride secretion. Am J Physiol Gastrointest Liver Physiol 283 (2002) G923-G931
26. Sasaki T., Hiwatashi N., Yamazaki H., et al. The role of interferon-γ in the pathogenesis of Crohn's disease. Gastroenterol Jpn 27 (1992) 29-36
27. Heinonen K.M., Nestel F.P., Newell E.W., et al. T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood 103 (2004) 3457-3464
28. Bromberg J.F., Wrzeszczynska M.H., Devgan G., et al. Stat3 as an oncogene. Cell 98 (1999) 295-303
29. Klampfer L. The role of signal transducers and activators of transcription in colon cancer. Front Biosci 13 (2008) 2888-2899
30. Hardie D.G., Salt I.P., Hawley S.A., et al. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 338 (1999) 717-722
31. Madara J.L., and Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83 (1989) 724-727
32. +-ATPase by interferon-γ down-regulates intestinal epithelial transport and barrier function. Gastroenterology 120 (2001) 1393-1403
33. +-ATPase in ulcerative colitis. J Pathol 204 (2004) 84-92
34. Schmitz H., Barmeyer C., Fromm M., et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116 (1999) 301-309
35. Van Itallie C.M., Fanning A.S., and Anderson J.M. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol 285 (2003) F1078-F1084
36. Mankertz J., and Schulzke J.D. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 23 (2007) 379-383
37. Furuse M., Sasaki H., and Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 147 (1999) 891-903
38. Watson C.J., Hoare C.J., Garrod D.R., et al. Interferon-γ selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores. J Cell Sci 118 (2005) 5221-5230
39. Sakaguchi T., Gu X., Golden H.M., et al. Cloning of the human claudin-2 5′-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1α. J Biol Chem 277 (2002) 21361-21370
40. Ehret G.B., Reichenbach P., Schindler U., et al. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem 276 (2001) 6675-6688